Netherlands Journal

netherlands journal of critical care
Conclusion
Fluids are commonly given to prevent deterioration of renal function
in hypovolaemia, sepsis, contrast nephropathy and administration
of nephrotoxins. Summarising the current evidence, no clear highgrade
recommendation can be given regarding the type of hydration
regimen. Crystalloids appear to be safe in many settings, but exert
less volume effect and may aggravate extravascular oedema. On the
other hand, HES exerts larger volume effect, but caution is warranted
when using high molecular weight HES with a higher degree of substitution
as they may impair renal function. Albumin appears to be
safe with regard to renal function.
References
1. Groeneveld AB, Tran,DD, van der,MJ, Nauta,JJ, Thijs,LG.
Acute renal failure in the medical intensive care unit:
predisposing, complicating factors and outcome. Nephron
1991;59:602-610.
2. Schaefer JH, Jochimsen,F, Keller,F, Wegscheider,K,
Distler,A. Outcome prediction of acute renal failure in
medical intensive care. Intensive Care Med 1991;17:19-
24.
3. Schwilk B, Wiedeck,H, Stein,B, Reinelt,H, Treiber,H,
Bothner,U. Epidemiology of acute renal failure and outcome
of haemodiafiltration in intensive care. Intensive
Care Med 1997;23:1204-1211.
4. de Mendonca A, Vincent,JL, Suter,PM, Moreno,R,
Dearden,NM, Antonelli,M, Takala,J, Sprung,C,
Cantraine,F. Acute renal failure in the ICU: risk factors
and outcome evaluated by the SOFA score. Intensive
Care Med 2000;26:915-921.
5. Storset P, Smith-Erichsen,N, Vaagenes,P. Organ function
during early acute renal failure does not predict
survival in long-term intensive care. Intensive Care Med
1995;21:797-801.
6. Cosentino F, Chaff,C, Piedmonte,M. Risk factors influencing
survival in ICU acute renal failure. Nephrol Dial
Transplant 1994;9 Suppl 4:179-82.:179-182.
7. Liano F, Junco,E, Pascual,J, Madero,R, Verde,E. The spectrum
of acute renal failure in the intensive care unit
compared with that seen in other settings. The Madrid
Acute Renal Failure Study Group. Kidney Int Suppl
1998;66:S16-24.:S16-S24.
8. Guerin C, Girard,R, Selli,JM, Perdrix,JP, Ayzac,L. Initial
versus delayed acute renal failure in the intensive care
unit. A multicenter prospective epidemiological study.
Rhone-Alpes Area Study Group on Acute Renal Failure.
Am J Respir Crit Care Med 2000;161:872-879.
9. Joannidis M, Metnitz,PG. Epidemiology and natural
history of acute renal failure in the ICU. Crit Care Clin
2005;21:239-249.
10. Rackow EC, Falk,JL, Fein,IA, Siegel,JS, Packman,MI,
Haupt,MT, Kaufman,BS, Putnam,D. Fluid resuscitation in
circulatory shock: a comparison of the cardiorespiratory
effects of albumin, hetastarch, and saline solutions in
patients with hypovolemic and septic shock. Crit Care
Med 1983;11:839-850.
11. Erley CM. Does hydration prevent radiocontrastinduced
acute renal failure? Nephrol Dial Transplant
1999;14:1064-1066.
12. Prasad PV, Epstein,FH. Changes in renal medullary pO2
during water diuresis as evaluated by blood oxygenation
level-dependent magnetic resonance imaging:
effects of aging and cyclooxygenase inhibition. Kidney
Int 1999;55:294-298.
13. Wilkes NJ, Woolf,R, Mutch,M, Mallett,SV, Peachey,T,
Stephens,R, Mythen,MG. The effects of balanced versus
saline-based hetastarch and crystalloid solutions on
acid-base and electrolyte status and gastric mucosal
perfusion in elderly surgical patients. Anesth Analg
2001;93:811-816.
14. Horstick G, Lauterbach,M, Kempf,T, Bhakdi,S,
Heimann,A, Horstick,M, Meyer,J, Kempski,O. Early albumin
infusion improves global and local hemodynamics
and reduces inflammatory response in hemorrhagic
shock. Crit Care Med 2002;30:851-855.
15. Zhang H, Voglis,S, Kim,CH, Slutsky,AS. Effects of albumin
and Ringer’s lactate on production of lung cytokines
and hydrogen peroxide after resuscitated hemorrhage
and endotoxemia in rats. Crit Care Med 2003;31:1515-
1522.
16. Inoue M, Okajima,K, Itoh,K, Ando,Y, Watanabe,N,
Yasaka,T, Nagase,S, Morino,Y. Mechanism of furosemide
resistance in analbuminemic rats and hypoalbuminemic
patients. Kidney Int 1987;32:198-203.
17. Finfer S, Bellomo,R, Boyce,N, French,J, Myburgh,J,
Norton,R. A comparison of albumin and saline for fluid
resuscitation in the intensive care unit. N Engl J Med
2004;350:2247-2256.
18. Beyer R, Harmening,U, Rittmeyer,O, Zielmann,S,
Mielck,F, Kazmaier,S, Kettler,D. Use of modified fluid
gelatin and hydroxyethyl starch for colloidal volume
replacement in major orthopaedic surgery. Br J Anaesth
1997;78:44-50.
19. Schortgen F, Lacherade,JC, Bruneel,F, Cattaneo,I,
Hemery,F, Lemaire,F, Brochard,L. Effects of hydroxyethylstarch
and gelatin on renal function in severe sepsis: a
multicentre randomised study. Lancet 2001;357:911-916.
20. Tabuchi N, de Haan,J, Gallandat Huet,RC, Boonstra,PW,
van Oeveren,W. Gelatin use impairs platelet adhesion
during cardiac surgery. Thromb Haemost 1995;74:1447-
1451.
21. Mardel SN, Saunders,FM, Allen,H, Menezes,G,
Edwards,CM, Ollerenshaw,L, Baddeley,D, Kennedy,A,
Ibbotson,RM. Reduced quality of clot formation
with gelatin-based plasma substitutes. Br J Anaesth
1998;80:204-207.
22. Messmer KF. The use of plasma substitutes with special
attention to their side effects. World J Surg 1987;11:69-
74.
23. Laxenaire MC, Charpentier,C, Feldman,L. [Anaphylactoid
reactions to colloid plasma substitutes: incidence, risk
factors, mechanisms. A French multicenter prospective
study]. Ann Fr Anesth Reanim 1994;13:301-310.
24. Kurnik BR, Singer,F, Groh,WC. Case report: dextraninduced
acute anuric renal failure. Am J Med Sci
1991;302:28-30.
25. Mailloux L, Swartz,CD, Capizzi,R, Kim,KE, Onesti,G,
Ramirez,O, Brest,AN. Acute renal failure after administration
of low-molecular weight dextran. N Engl J Med
1967;277:1113-1118.
26. Legendre C, Thervet,E, Page,B, Percheron,A, Noel,LH,
Kreis,H. Hydroxyethylstarch and osmotic-nephrosis-like
lesions in kidney transplantation. Lancet 1993;342:248-
249.
27. Kief H, Engelbart,K. [Reabsorptive vacuolization of the
contorted main parts of the kidney (so-called osmotic
nephrosis)]. Frankf Z Pathol 1966;75:53-65.
28. Bork K. Pruritus precipitated by hydroxyethyl starch: a
review. Br J Dermatol 2005;152:3-12.
29. Boldt J, Priebe,HJ. Intravascular volume replacement
therapy with synthetic colloids: is there an influence on
renal function? Anesth Analg 2003;96:376-82, Table.
30. Winkelmayer WC, Glynn,RJ, Levin,R, Avorn,J. Hydroxyethyl
starch and change in renal function in patients
undergoing coronary artery bypass graft surgery. Kidney
Int 2003;64:1046-1049.
31. Huang PP, Stucky,FS, Dimick,AR, Treat,RC, Bessey,PQ,
Rue,LW. Hypertonic sodium resuscitation is associated
with renal failure and death. Ann Surg 1995;221:543-554.
32. Dellinger RP, Carlet,JM, Masur,H, Gerlach,H, Calandra,T,
Cohen,J, Gea-Banacloche,J, Keh,D, Marshall,JC,
Parker,MM, Ramsay,G, Zimmerman,JL, Vincent,JL,
Levy,MM. Surviving Sepsis Campaign guidelines for
management of severe sepsis and septic shock. Intensive
Care Med 2004;30:536-555.
33. Dehne MG, Muhling,J, Sablotzki,A, Dehne,K, Sucke,N,
Hempelmann,G. Hydroxyethyl starch (HES) does not
directly affect renal function in patients with no prior
renal impairment. J Clin Anesth 2001;13:103-111.
34. London MJ, Ho,JS, Triedman,JK, Verrier,ED, Levin,J,
Merrick,SH, Hanley,FL, Browner,WS, Mangano,DT. A randomized
clinical trial of 10% pentastarch (low molecular
weight hydroxyethyl starch) versus 5% albumin for
plasma volume expansion after cardiac operations. J
Thorac Cardiovasc Surg 1989;97:785-797.
35. Stockwell MA, Scott,A, Day,A, Riley,B, Soni,N. Colloid
solutions in the critically ill. A randomised comparison
of albumin and polygeline 2. Serum albumin concentration
and incidences of pulmonary oedema and acute
renal failure. Anaesthesia 1992;47:7-9.
36. Vogt NH, Bothner,U, Lerch,G, Lindner,KH, Georgieff,M.
Large-dose administration of 6% hydroxyethyl starch
200/0.5 total hip arthroplasty: plasma homeostasis,
hemostasis, and renal function compared to use of 5%
human albumin. Anesth Analg 1996;83:262-268.
37. Kumle B, Boldt,J, Piper,S, Schmidt,C, Suttner,S, Salopek,S.
The influence of different intravascular volume replacement
regimens on renal function in the elderly. Anesth
Analg 1999;89:1124-1130.
38. Allison KP, Gosling,P, Jones,S, Pallister,I, Porter,KM. Randomized
trial of hydroxyethyl starch versus gelatine for
trauma resuscitation. J Trauma 1999;47:1114-1121.
39. Boldt J, Brenner,T, Lehmann,A, Lang,J, Kumle,B,
Werling,C. Influence of two different volume replacement
regimens on renal function in elderly patients
undergoing cardiac surgery: comparison of a new
starch preparation with gelatin. Intensive Care Med
2003;29:763-769.
40. Sedrakyan A, Gondek,K, Paltiel,D, Elefteriades,JA.
Volume expansion with albumin decreases mortality
after coronary artery bypass graft surgery. Chest
2003;123:1853-1857.
41. Bickell WH, Wall,MJ, Jr., Pepe,PE, Martin,RR, Ginger,VF,
Allen,MK, Mattox,KL. Immediate versus delayed fluid
resuscitation for hypotensive patients with penetrating
torso injuries. N Engl J Med 1994;331:1105-1109.
42. Heemskerk AE, Huisman,E, van Lambalgen,AA, van den
Bos,GC, Hennekes,MW, Thijs,LG, Tangelder,GJ. Influence
of fluid resuscitation on renal function in bacteremic
and endotoxemic rats. J Crit Care 1997;12:120-131.
43. Van Biesen W, Yegenaga,I, Vanholder,R, Verbeke,F,
Hoste,E, Colardyn,F, Lameire,N. Relationship between
fluid status and its management on acute renal failure
(ARF) in intensive care unit (ICU) patients with sepsis: a
prospective analysis. J Nephrol 2005;18:54-60.
44. Rivers E, Nguyen,B, Havstad,S, Ressler,J, Muzzin,A,
Knoblich,B, Peterson,E, Tomlanovich,M. Early goaldirected
therapy in the treatment of severe sepsis and
septic shock. N Engl J Med 2001;345:1368-1377.
45. Boldt J, Lehmann,A, Rompert,R, Haisch,G, Isgro,F. Volume
therapy with a new hydroxyethyl starch solution
in cardiac surgical patients before cardiopulmonary
bypass. J Cardiothorac Vasc Anesth 2000;14:264-268.
552
neth j crit care • volume 10 • no 5 • october 2006